254 related articles for article (PubMed ID: 9606287)
1. Effect of subtotal thyroidectomy on natural history of ophthalmopathy in Graves' disease.
Abe Y; Sato H; Noguchi M; Mimura T; Sugino K; Ozaki O; Yoshimura H; Ito K
World J Surg; 1998 Jul; 22(7):714-7. PubMed ID: 9606287
[TBL] [Abstract][Full Text] [Related]
2. Relationship between Graves' ophthalmopathy and type of treatment of Graves' hyperthyroidism.
Marcocci C; Bartalena L; Bogazzi F; Bruno-Bossio G; Pinchera A
Thyroid; 1992; 2(2):171-8. PubMed ID: 1525588
[TBL] [Abstract][Full Text] [Related]
3. Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group.
Tallstedt L; Lundell G; Tørring O; Wallin G; Ljunggren JG; Blomgren H; Taube A
N Engl J Med; 1992 Jun; 326(26):1733-8. PubMed ID: 1489388
[TBL] [Abstract][Full Text] [Related]
4. Graves' ophthalmopathy after subtotal thyroidectomy and radioiodine therapy.
Fernández Sánchez JR; Rosell Pradas J; Carazo Martinez O; Torres Vela E; Escobar Jimenez F; Garbin Fuentes I; Vara Thorbeck R
Br J Surg; 1993 Sep; 80(9):1134-6. PubMed ID: 8402112
[TBL] [Abstract][Full Text] [Related]
5. Thyroidectomy remains an effective treatment option for Graves' disease.
Weber KJ; Solorzano CC; Lee JK; Gaffud MJ; Prinz RA
Am J Surg; 2006 Mar; 191(3):400-5. PubMed ID: 16490555
[TBL] [Abstract][Full Text] [Related]
6. The course of Graves' ophthalmopathy is not influenced by near total thyroidectomy: a case-control study.
Marcocci C; Bruno-Bossio G; Manetti L; Tanda ML; Miccoli P; Iacconi P; Bartolomei MP; Nardi M; Pinchera A; Bartalena L
Clin Endocrinol (Oxf); 1999 Oct; 51(4):503-8. PubMed ID: 10583319
[TBL] [Abstract][Full Text] [Related]
7. Randomized clinical trial of bilateral subtotal thyroidectomy versus total thyroidectomy for Graves' disease with a 5-year follow-up.
Barczyński M; Konturek A; Hubalewska-Dydejczyk A; Gołkowski F; Nowak W
Br J Surg; 2012 Apr; 99(4):515-22. PubMed ID: 22287122
[TBL] [Abstract][Full Text] [Related]
8. Regression of Ophthalmopathic Exophthalmos in Graves' Disease After Total Thyroidectomy: a Prospective Study of a Surgical Series.
Bhargav PRK; Sabaretnam M; Kumar SC; Zwalitha S; Devi NV
Indian J Surg; 2017 Dec; 79(6):521-526. PubMed ID: 29217903
[TBL] [Abstract][Full Text] [Related]
9. The late effect of subtotal thyroidectomy and radioactive iodine therapy on calcitonin secretion and bone mineral density in women treated for Graves' disease.
Lowery WD; Thomas CG; Awbrey BJ; Rosenstein BD; Talmage RV
Surgery; 1986 Dec; 100(6):1142-9. PubMed ID: 3787472
[TBL] [Abstract][Full Text] [Related]
10. Graves' ophthalmopathy: the case for thyroid surgery.
Lowery AJ; Kerin MJ
Surgeon; 2009 Oct; 7(5):290-6. PubMed ID: 19848063
[TBL] [Abstract][Full Text] [Related]
11. Treatment of patients with Graves' disease and the appropriate extent of thyroidectomy.
Bobanga ID; McHenry CR
Best Pract Res Clin Endocrinol Metab; 2019 Aug; 33(4):101319. PubMed ID: 31530446
[TBL] [Abstract][Full Text] [Related]
12. Chronology of Graves' ophthalmopathy in an incidence cohort.
Bartley GB; Fatourechi V; Kadrmas EF; Jacobsen SJ; Ilstrup DM; Garrity JA; Gorman CA
Am J Ophthalmol; 1996 Apr; 121(4):426-34. PubMed ID: 8604736
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome of Graves' disease patients treated in a region with iodine deficiency: relapse rate increases in years with thionamides.
Tütüncü NB; Tütüncü T; Ozgen A; Erbas T
J Natl Med Assoc; 2006 Jun; 98(6):926-30. PubMed ID: 16775915
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Graves' disease and the course of ophthalmopathy.
Sridama V; DeGroot LJ
Am J Med; 1989 Jul; 87(1):70-3. PubMed ID: 2741983
[TBL] [Abstract][Full Text] [Related]
15. Thyroid cancer in Graves' disease: is surgery the best treatment for Graves' disease?
Tamatea JA; Tu'akoi K; Conaglen JV; Elston MS; Meyer-Rochow GY
ANZ J Surg; 2014 Apr; 84(4):231-4. PubMed ID: 22985335
[TBL] [Abstract][Full Text] [Related]
16. Total thyroidectomy for the treatment of recurrent graves' disease with ophthalmopathy.
Nart A; Uslu A; Aykas A; Yuzbasioglu F; Dogan M; Demirtas O; Simsek C
Asian J Surg; 2008 Jul; 31(3):115-8. PubMed ID: 18658008
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Graves' disease: the advantages of surgery.
Alsanea O; Clark OH
Endocrinol Metab Clin North Am; 2000 Jun; 29(2):321-37. PubMed ID: 10874532
[TBL] [Abstract][Full Text] [Related]
18. The influence of surgery on endocrine ophthalmopathy.
Frilling A; Goretzki PE; Grussendorf M; Erbslöh M; Röher HD
World J Surg; 1990; 14(3):442-5; discussion 445-6. PubMed ID: 2368450
[TBL] [Abstract][Full Text] [Related]
19. Total thyroidectomy in therapy-resistant Graves' disease.
Winsa B; Rastad J; Larsson E; Mandahl A; Westermark K; Johansson H; Juhlin C; Karlsson A; Akerström G
Surgery; 1994 Dec; 116(6):1068-74; discussion 1074-5. PubMed ID: 7985089
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of soluble Fas in patients with Graves' ophthalmopathy.
Ohtsuka K; Hashimoto M
Br J Ophthalmol; 2000 Jan; 84(1):103-6. PubMed ID: 10611108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
